Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?

Get ready for a world of million-dollar drugs. Pricey gene therapies that could cure devastating genetic disorders in one fell swoop are gaining momentum, brightening the horizon for biotech stocks like Sarepta Therapeutics (SRPT) and BioMarin Pharmaceutical (BMRN).